Overview

Bringing Attention to Racial Disparities in Clinical Trials

Clinical trials are a lifeline, and often the only way someone with advanced cancer can survive. Disparities in clinical trials among African Americans and Hispanic communities is a longstanding problem. African Americans are 13% of the U.S population yet only 3% of patients in oncology trials. Hispanics are 19% of the U.S population yet only 6% of patients in oncology trials.

FCB Health New York launched “The Trial for #ClinicalEquality” to educate healthcare professionals, researchers, politicians, patient advocacy groups, and the public about changing the practices of clinical trials.

My Role

I worked on a team collaborating with an art director, copywriter, and UX architect to launch an initiative that informs the public of the ongoing issues in clinical trials. Our user end goal was to urge users to sign a petition on change.org to end racial disparity in clinical trials.